Hodgkin's lymphoma, also known as Hodgkin's disease, develops mainly in young adults and is considered a very treatable cancer. In this Patient Power program, sponsored by The University of Texas M. D. Anderson Cancer Center you’ll hear from two inspiring patients and their doctors,as they discuss the latest in the treatment and research of Hodgkin’s disease and, in particular, new hope for people whose Hodgkin's disease has relapsed.
The program opens with 19-year-old Alexandra. She talks about her initial diagnosis several years ago, how it affected her life and her treatment at M. D. Anderson. When her cancer recurred, she returned to M. D. Anderson and is currently participating in a clinical trial. Next we hear from Brandy, a 36-year-old whose Hodgkin’s disease recurred in 2007. That’s when she sought treatment at M. D. Anderson. Both Brandy and Alexandra discuss their specific treatments, and speak highly of not only the care they have received but of the relationships they have formed with their respective physicians.
Dr. Ana Younes, director of the clinical and translational research program in the department of lymphoma/myeloma at M. D. Anderson, joins the program to help listeners understand Hodgkin’s disease. Dr. Michelle Fanale, assistant professor in the department of lymphoma/myeloma, discusses treatment approaches, clinical trials and varying responses to therapy. She also shares specific details of the therapies that Alexandra and Brandy have received. Both experts share their perspective on research and the outlook for the future of Hodgkin’s disease treatment. If you’ve been looking for information about Hodgkin’s disease, this program is a great educational resource.
Produced in association with The University of Texas MD Anderson Cancer Center
Be the first to know about new programs and information with)Lymphoma email alerts.
Hodgkin's lymphoma, also known as Hodgkin's disease, develops mainly in young adults, and it's considered very treatable as a cancer. Coming up you'll hear two inspiring patients and their doctors, leading experts in the field as they discuss the latest treatment for Hodgkin's disease and in particular new hope for people when Hodgkin's disease has relapsed. That's all next on Patient Power sponsored by M. D. Anderson Cancer Center.
Hello and welcome to Patient Power sponsored by M. D. Anderson Cancer Center. I'm Andrew Schorr. Well, there are good kinds of cancer, so called, and some that are less good. One that's normally considered very treatable is Hodgkin's disease or Hodgkin's lymphoma, and often people can be treated and cured and go on with their lives, but it doesn't always work out that way. Now, the good news you'll learn in this program is there's a lot of research going on particularly at M. D. Anderson Cancer Center. We're going to hear about that in a minute, but first I'd like you to meet two people, different age women, one 19 and one who is in her 30s, 36 actually, and you'll hear how they were helped when they were treated for their recurrences of Hodgkin's lymphoma at M. D. Anderson.